Showing results (21-30 of 71) with videos related to
Sort By:
Pageof 8
Journal of Clinical Microbiology|April 17, 2015
Genotype- and Subtype-Independent Full-Genome Sequencing Assay for Hepatitis C VirusCharlotte Hedskog, Krishna Chodavarapu, Karin S Ku, et al.Antimicrobial Agents and Chemotherapy|July 24, 2013
Characterization of Hepatitis C virus resistance from a multiple-dose clinical trial of the novel NS5A inhibitor GS-5885Kelly A Wong, Angela Worth, Ross Martin, et al.Viruses|December 23, 2015
Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR StudyDanielle P Porter, Martin Daeumer, Alexander Thielen, et al.Journal of Viral Hepatitis|April 23, 2019
In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6Hadas Dvory-Sobol, Bin Han, Julia Lu, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2020
Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI ResistanceRima K Acosta, Madeleine Willkom, Kristen Andreatta, et al.Journal of Clinical Microbiology|February 8, 2019
<i>In Vitro</i> Susceptibility of Hepatitis C Virus Genotype 1 through 6 Clinical Isolates to the Pangenotypic NS3/4A Inhibitor VoxilaprevirBin Han, Bandita Parhy, Julia Lu, et al.Drug Design, Development and Therapy|July 1, 2015
The impact of lipocalin-type-prostaglandin-D-synthase as a predictor of kidney disease in patients with type 2 diabetesMarcelo Rodrigues Bacci, Marina Romera Cavallari, Ross Martin de Rozier-Alves, et al.The Journal of Infectious Diseases|November 8, 2025
Resistance Analysis of Low-Level Virologic Rebound During HIV-1 Treatment with Lenacapavir and Broadly Neutralizing Antibodies Teropavimab and ZinlirvimabLisa Selzer, Sally Demirdjian, Brie Falkard, et al.Mbio|April 17, 2025
Impact of HIV-1 capsid polymorphisms on viral infectivity and susceptibility to lenacapavirDerek Hansen, Matthew R Hendricks, Silvia Chang, et al.The Journal of Antimicrobial Chemotherapy|April 21, 2021
Three-year study of pre-existing drug resistance substitutions and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in HIV-1 treatment-naive participantsRima K Acosta, Grace Q Chen, Silvia Chang, et al.Pageof 8